Based on the Celadon Pharmaceuticals PLC stock forecast from 0 analysts, the average analyst target price for Celadon Pharmaceuticals PLC is not available over the next 12 months. Celadon Pharmaceuticals PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Celadon Pharmaceuticals PLC is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Celadon Pharmaceuticals PLC’s stock price was GBX 29.50. Celadon Pharmaceuticals PLC’s stock price has changed by +7.27% over the past week, -16.90% over the past month and -69.74% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for CEL:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
